Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related EXEL
Exelixis Spikes Following Phase 3 Results Of Cabozantinib; EU Filing Planned For Early 2016
Benzinga's Top #PreMarket Gainers
Related JEC
Earnings Scheduled For February 3, 2016
Jacobs Engineering's Stock Gains Following Contract Win

Exelixis (NASDAQ: EXEL) added 10.63% to $7.08 in the pre-market session. Exelixis reported that the US Food and Drug Administration (FDA) has granted priority review for cabozantinib in medullary thyroid cancer.

Jacobs Engineering Group (NYSE: JEC) soared 6.19% to $41.89 in the pre-market trading. Jacobs Engineering is expected to report its third-quarter earnings after the closing bell.

Sprint Nextel (NYSE: S) surged 4.64% to $4.51 in the pre-market session. Sprint Nextel's trailing-twelve-month revenue is $34.63 billion.

Fluor (NYSE: FLR) moved up 4.43% to $52.82 in the pre-market session. Fluor's PEG ratio is 1.23.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (EXEL + FLR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters